Acadia Healthcare (NASDAQ:ACHC) PT Lowered to $91.00

Acadia Healthcare (NASDAQ:ACHC) had its target price lowered by Barclays from $100.00 to $91.00 in a report published on Thursday, Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other equities analysts have also recently weighed in on the stock. TD Cowen upped their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an outperform rating in a research report on Friday, March 1st. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price objective for the company in a research note on Thursday, April 25th. Cantor Fitzgerald reaffirmed a neutral rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, March 5th. TheStreet raised shares of Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. Finally, Royal Bank of Canada reaffirmed an outperform rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus target price of $89.50.

Acadia Healthcare Stock Down 0.9 %

Shares of NASDAQ ACHC traded down $0.61 on Thursday, hitting $66.12. The company had a trading volume of 1,181,258 shares, compared to its average volume of 604,466. The firm has a market capitalization of $6.11 billion, a P/E ratio of -472.29, a PEG ratio of 2.15 and a beta of 1.31. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 12-month low of $64.74 and a 12-month high of $87.77. The business has a 50 day moving average of $77.13 and a two-hundred day moving average of $77.61.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The firm had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.56% and a negative net margin of 0.38%. Acadia Healthcare’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.75 EPS. As a group, equities research analysts forecast that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the stock. Quent Capital LLC grew its stake in Acadia Healthcare by 8.1% during the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after buying an additional 284 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Acadia Healthcare by 77.1% during the first quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock worth $1,700,000 after acquiring an additional 9,342 shares during the last quarter. Peterson Wealth Services acquired a new stake in shares of Acadia Healthcare in the 1st quarter worth about $2,739,000. Retirement Systems of Alabama lifted its position in Acadia Healthcare by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock valued at $9,174,000 after purchasing an additional 303 shares during the last quarter. Finally, OFI Invest Asset Management boosted its stake in Acadia Healthcare by 2.5% during the 1st quarter. OFI Invest Asset Management now owns 164,427 shares of the company’s stock valued at $12,061,000 after purchasing an additional 4,013 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.